Dr. Rachel Schindler is a neurologist with subspecialty training in Neuropsychiatry and Behavioral Neurology. After completing her training, she was Director of Behavioral Neurology and Neuropsychiatry, Chief of Neurorehabilitation, and Assistant Professor of Neurology at the State University of New York at Stony Brook. There, she founded and directed The Neurobehavior and Memory Disorders Program, a comprehensive multidisciplinary program serving patients and their families with neurobehavioral and memory disorders related to Alzheimer’s disease and other dementias, head injury, stroke, epilepsy, and other neurological disorders.
In 2000, Dr. Schindler joined Pfizer, where she is currently Vice President, Clinical Disease Area Expert in Alzheimer’s disease. In addition to her leadership role in development of medications and setting strategy for Alzheimer’s disease, she has been involved in various U.S. and global initiatives and consensus groups to advance research, public policy, and the care of Alzheimer’s patients.
Currently, Dr. Schindler is the Co-Chair of the Alzheimer’s Association Research Roundtable and Chair of the Medical and Scientific Advisory Board of the Long Island Alzheimer’s Foundation.